by Patrick ➕follow (55) 💰tip ignore
Comments 1 - 9 of 9 Search these comments
US Set to Pay $712 Per Patient for Merck’s COVID-19 Pill
BY ZACHARY STIEBER October 16, 2021
Merck is set to get $712 per treatment course for its COVID-19 pill from the U.S. government—even as it costs a fraction of that to produce, and is reportedly on track for a price of $12 in India.
More than two-thirds of Congress cashed a pharma campaign check in 2020, new STAT analysis shows
Urgent call to action! The FDA wants to approve Pfizer mRNA shots for 19 million kids ages 6-months to 4-years old
There is no data to support such a decision. We have 14 days to stop the FDA from committing a crime against humanity
The cost is not fraction of that, it costs about 1 -2 billion , n 10 years to get pill into market. This was expedited so might cost even more , but shorter human trial.
patrick.net
An Antidote to Corporate Media
1,183,597 comments by 13,785 users - NewGuy, WookieMan online now